Here's the live share price of Procter & Gamble Health along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Procter & Gamble Health | -0.61 | 8.80 | 35.23 | 24.79 | 15.62 | 9.82 | 4.04 |
| Sun Pharmaceutical Industries | -0.11 | 6.22 | 15.40 | 15.51 | 13.49 | 21.51 | 22.92 |
| Divi's Laboratories | 6.18 | 8.98 | 16.52 | 18.19 | 6.97 | 25.63 | 8.62 |
| Torrent Pharmaceuticals | -2.79 | 7.15 | 14.06 | 16.52 | 36.02 | 34.91 | 26.26 |
| Zydus Lifesciences | -0.67 | 7.65 | 21.24 | 29.70 | 16.37 | 23.81 | 12.31 |
| Cipla | -1.41 | 5.01 | 14.54 | 1.96 | -4.32 | 11.17 | 7.81 |
| Lupin | -2.19 | 7.71 | 5.04 | 12.09 | 24.86 | 37.76 | 15.55 |
| Mankind Pharma | -1.32 | 5.41 | 17.34 | 17.64 | -5.65 | 10.55 | 11.84 |
| Dr. Reddy's Laboratories | -2.78 | -4.58 | -1.99 | 3.81 | -4.15 | 4.99 | 2.24 |
| Aurobindo Pharma | -1.89 | 7.95 | 10.79 | 31.52 | 33.03 | 27.70 | 9.73 |
| Laurus Labs | -0.56 | 11.74 | 34.77 | 43.97 | 86.19 | 63.28 | 18.14 |
| Biocon | 4.43 | 6.15 | 22.00 | 16.22 | 10.12 | 18.15 | 1.23 |
| Alkem Laboratories | -2.16 | 3.74 | -0.66 | -3.39 | 10.63 | 15.21 | 9.98 |
| Glenmark Pharmaceuticals | -2.03 | 4.71 | -0.53 | 12.32 | 0.42 | 47.13 | 26.81 |
| Abbott India | 3.28 | 7.95 | 8.59 | 0.86 | -17.92 | 6.56 | 10.08 |
| Ipca Laboratories | 7.35 | 24.75 | 30.72 | 28.95 | 30.17 | 34.61 | 12.63 |
| Anthem Biosciences | 3.33 | 1.58 | 8.29 | 26.81 | 6.78 | 2.21 | 1.32 |
| Ajanta Pharma | 1.87 | 10.71 | 22.36 | 27.01 | 22.41 | 33.54 | 19.08 |
| GlaxoSmithKline Pharmaceuticals | 1.01 | 11.88 | 0.33 | 5.60 | -22.40 | 20.18 | 8.89 |
| Gland Pharma | -1.20 | 11.50 | 36.42 | 45.95 | 22.00 | 27.87 | -8.69 |
Source: Dion Global
Over the last one year, Procter & Gamble Health has gained 15.62% compared to peers like Sun Pharmaceutical Industries (13.49%), Divi's Laboratories (6.97%), Torrent Pharmaceuticals (36.02%). From a 5 year perspective, Procter & Gamble Health has underperformed peers relative to Sun Pharmaceutical Industries (22.92%) and Divi's Laboratories (8.62%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 6,822.13 | 6,786.31 |
| 10 | 6,577.49 | 6,643.47 |
| 20 | 6,425.86 | 6,468.12 |
| 50 | 6,012.38 | 6,092.8 |
| 100 | 5,490.53 | 5,805.95 |
| 200 | 5,640.19 | 5,675.44 |
Source: Dion Global
In the latest quarter, Procter & Gamble Health remained same as its previous close in promoter holding, while DII stake decreased to 12.44%, FII holding rose to 6.33%, and public shareholding moved up to 29.41% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,94,659 | 0.56 | 439.48 | |
| 2,14,559 | 5 | 135.74 | |
| 1,59,288 | 2.87 | 100.77 | |
| 94,716 | 1.85 | 59.92 | |
| 84,736 | 0.57 | 53.61 | |
| 50,000 | 2.42 | 31.63 | |
| 44,504 | 0.47 | 28.16 | |
| 41,132 | 1.79 | 26.02 | |
| 35,195 | 2.2 | 22.27 | |
| 28,381 | 1.03 | 17.96 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 15, 2026, 11:55 PM IST IST | P&G Health - Update Regarding Company'S Annual General Meeting For The Financial Year 2025-26 And Record Date |
| Jul 03, 2026, 11:34 PM IST IST | P&G Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jun 26, 2026, 11:50 PM IST IST | P&G Health - Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gam |
| Jun 26, 2026, 09:41 PM IST IST | P&G Health - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6, 2026 |
| Jun 26, 2026, 01:31 AM IST IST | P&G Health - Announcement under Regulation 30 (LODR)-Change in Management |
Source: Dion Global
Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 1407.97 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Procter & Gamble Health is ₹6,790.20 as on Jul 17, 2026.
The Procter & Gamble Health is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Procter & Gamble Health is ₹11,271.31 Cr as on Jul 17, 2026.
Today’s highest and lowest price of Procter & Gamble Health are ₹6,845.00 and ₹6,755.00.
The 52-week high/low is the highest and lowest price at which Procter & Gamble Health stock has traded in the past 52-week or nearly a year. The 52-week high of Procter & Gamble Health is ₹6,955.00 and 52-week low of Procter & Gamble Health is ₹4,699.70 as on Jul 17, 2026.
The Procter & Gamble Health has shown returns of -0.87% over the past day, 8.8% for the past month, 35.23% over 3 months, 15.62% over 1 year, 9.82% across 3 years, and 4.04% over 5 years.
P/E ratio of and PB ratio of Procter & Gamble Health are 34.48 and 21.49 on Jul 17, 2026. While the company gives a dividend yield of 0.66 per annum.
Source: Dion Global